These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26267685)

  • 1. [Effect of alprostadil on serum level of miRNA-155 
in uremic patients].
    Zhang W; Shi L; Zhang H; Wang C; Gao S; Ma Y; Li W; Liu J; Wang J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 40(7):735-41. PubMed ID: 26267685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum hepcidin levels are associated with serum triglycerides and interleukin-6 concentrations in patients with end-stage renal disease.
    Samouilidou E; Pantelias K; Petras D; Tsirpanlis G; Bakirtzi J; Chatzivasileiou G; Tzanatos H; Grapsa E
    Ther Apher Dial; 2014 Jun; 18(3):279-83. PubMed ID: 24119290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imbalance of Th22/Treg cells causes microinflammation in uremic patients undergoing hemodialysis.
    Ren T; Xiong J; Liu G; Wang S; Tan Z; Fu B; Zhang R; Liao X; Wang Q; Guo Z
    Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31427482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
    Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
    Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel inflammatory marker in dialysis patients: YKL-40.
    Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
    Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of Prohepcidin levels with anemia and inflammatory markers in non-diabetic uremic patients: a controlled study.
    Aydin Z; Gursu M; Karadag S; Uzun S; Sumnu A; Doventas Y; Ozturk S; Kazancioglu R
    Ren Fail; 2014 Sep; 36(8):1253-7. PubMed ID: 25040737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease.
    Góes MA; Dalboni MA; Manfredi SR; Cendoroglo MS; Batista MC; Canziani ME; Balakrishnan VS; Pereira BJ; Draibe SA; Cendoroglo M
    Clin Nephrol; 2010 Jan; 73(1):7-13. PubMed ID: 20040346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blood purification on serum miR-126 and VEGF levels in the process of atherosclerosis in uremic patients under maintenance hemodialysis.
    Zhao D; Shao H
    Kaohsiung J Med Sci; 2018 Aug; 34(8):447-455. PubMed ID: 30041762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels.
    Preston GA; Barrett CV; Alcorta DA; Hogan SL; Dinwiddie L; Jennette JC; Falk RJ
    Nephron; 2002 Dec; 92(4):817-23. PubMed ID: 12399626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis-related transcriptomic profiling: the pivotal role of heparanase.
    Zaza G; Masola V; Granata S; Pontrelli P; Sallustio F; Gesualdo L; Gambaro G; Grandaliano G; Lupo A
    Exp Biol Med (Maywood); 2014 Jan; 239(1):52-64. PubMed ID: 24189015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
    Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
    Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expression.
    Stockler-Pinto MB; Soulage CO; Borges NA; Cardozo LFMF; Dolenga CJ; Nakao LS; Pecoits-Filho R; Fouque D; Mafra D
    Int Urol Nephrol; 2018 Feb; 50(2):347-354. PubMed ID: 29151180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
    Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
    Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatoin, oxidative stress and carbonyl stress in uremic patients].
    Li Z; Su BH; Mi XH; Liu XR; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):123-5. PubMed ID: 16468659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of uremia on cell viability and cytokine release of human peritoneal mesothelial cells.
    Plum J; Fleisch MC; Razeghi P; Fusshöller A; Lordnejad MR; Grabensee B
    Kidney Blood Press Res; 2002; 25(4):195-201. PubMed ID: 12424420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Uremic Pruritus in Patients Receiving Peritoneal Dialysis and Hemodialysis.
    Wu HY; Peng YS; Chen HY; Tsai WC; Yang JY; Hsu SP; Pai MF; Lu HM; Chiang JF; Ko MJ; Wen SY; Chiu HC
    Medicine (Baltimore); 2016 Mar; 95(9):e2935. PubMed ID: 26945400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
    Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.
    Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Filippi C; Mantuano E; Sidoti A; Grazi G; Antonelli A; Angelini D; Petrone I; Mura C; Tolaini P; Saloi F; Ghezzi PM; Barsotti G; Palla R
    Nephrol Dial Transplant; 2006 Mar; 21(3):756-62. PubMed ID: 16303780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of the intensity of uremic pruritus in patients receiving maintenance hemodialysis: A cross-sectional study.
    Zhao JH; Zhu QS; Li YW; Wang LL
    PLoS One; 2021; 16(1):e0245370. PubMed ID: 33471852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.